Safety/Efficacy of Valsartan/Hydrochlorothiazide Combination Compared to Hydrochlorothiazide in Obese Hypertensive Adults
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the blood pressure lowering efficacy of
valsartan/hydrochlorothiazide (HCTZ) compared to hydrochlorothiazide for the treatment of
obese hypertensive (mean sitting systolic blood pressure [MSSBP] >150 mmHg) patients.